Abivax, a clinical-stage biotechnology company, is on a roadshow in connection with its intention to issue 18,675,500 ordinary shares in an IPO of ADS, and a concurrent offering of ordinary…
Abivax, a clinical-stage biotechnology company, is on a roadshow in connection with its intention to issue 18,675,500 ordinary shares in an IPO of ADS, and a concurrent offering of ordinary…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference